Neuropharmacology & Neurotherapeutics
Nusinersen
Mar. 21, 2021
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Observed incidence and median (95% CI) pre-vaccination incidence based on the main and sensitivity analyses, Sweden 1910- to 2019. Gray-shaded areas represent pre-vaccination periods. CI, confidence interval. (Source: Martin LJ, Galanis I, Lepp T, Lindstrand A. Estimated number of reported vaccine-preventable disease cases averted following the introduction of routine vaccination programs in Sweden, 1910-2019. Eur J Public Health 2023;33[6]:1188-93. Creative Commons Attribution 4.0 International [CC BY 4.0] license, creativecommons.org/licenses/by/4.0. Modified by Dr. Douglas J Lanska to show only poliomyelitis cases with legend, whereas the original also showed curves for pertussis, measles, and mumps, and the legend was not connected with the poliomyelitis curve.)